Northway Biotech
24.5.2023 18:24:40 CEST | ACCESS Newswire | Press release
WALTHAM, MA / ACCESSWIRE / May 24, 2023 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech's standing as an influential player in the global biopharmaceutical landscape.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.This recent growth is an extension of the successful launch of Northway Biotech's process and analytical development laboratories in Waltham (Greater Boston area) in 2020. The expanded facility now includes state-of-the-art cGMP suites, marking a significant milestone in the company's journey. The newly established cutting-edge biomanufacturing suites host a microbial fermentation train with up to 450 liters of volume capacity, and a mammalian production train with the ability to handle volumes of up to 2,000 liters. Northway Biotech has further established a specialized, fully automated fill and finish line to accommodate its clients' varied needs, supporting high-throughput filling into vials, syringes, and cartridges.
Prof. Vladas Algirdas Bumelis, CEO of Northway Biotech, shared his insights regarding this accomplishment, stating, "The addition of GMP suites in our US site represents a transformative step for our organization, enabling us to provide comprehensive end-to-end solutions from our second site now. We are poised to transition current process development projects into the cGMP manufacturing phase in a timely manner, in line with our clients' committed schedules. Additionally, our longstanding US partners who have engaged with our Lithuanian site can now also take advantage of the geographical convenience of our modern facilities located in the Greater Boston Area. With our fully functional and technologically advanced manufacturing site at our disposal, Northway Biotech is perfectly positioned to take on manufacturing projects aimed at both clinical and commercial supply."
To commemorate this significant expansion and express gratitude to its valued partners and industry leaders, Northway Biotech will be hosting a grand opening event for its cGMP suites on June 8. This event promises to be an occasion of celebration and networking, providing an opportunity for attendees to witness firsthand the state-of-the-art facilities and engage in meaningful discussions within the biotech community.
About Northway Biotech - https://www.northwaybiotech.com
Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced, professional team executes projects at any stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing. Northway Biotech is a privately-owned company founded in 2004 and located in Vilnius, Lithuania; London, United Kingdom; and Waltham, Massachusetts, United States.
For Further Information, Contact:
Prof. Vladas Algirdas Bumelis
CEO and Chairman of the Board
Northway Biotech
vladas.bumelis@northwaybiotech.com
Contact Information
Vladas Bumelis
CEO and Chairman of the Board
vladas.bumelis@northwaybiotech.com
SOURCE: Northway Biotech
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/757061/Northway-Biotech-Set-to-Launch-Advanced-Microbial-and-Mammalian-GMP-Facilities-in-Massachusetts
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
IXOPAY Appoints Ajoy Krishnamoorthy as CEO to Accelerate Growth and Advance Payments for the Agentic Age25.8.2026 12:00:00 CEST | Press release
Enterprise Software and Commerce Leader Will Guide IXOPAY's Next Development Phase of Its Unified, AI-Native Payments Infrastructure Platform DALLAS, TX / ACCESS Newswire / August 25, 2026 / IXOPAY, the payment infrastructure solution that enables fluid commerce, today announced the appointment of Ajoy Krishnamoorthy as CEO. Krishnamoorthy brings more than two decades of enterprise software leadership and extensive product engineering experience turning complex technologies into platforms that businesses depend on to grow. Krishnamoorthy joins IXOPAY at a pivotal moment, as it helps unlock fluid commerce for enterprise merchants. Krishnamoorthy will focus on bringing IXOPAY's modular product suite into the agentic age, providing merchants with the freedom to buy what they need and build what they want in scaling their global payment operations. He comes with a customer-first mindset, ensuring momentum is maintained, and support is given to customers during this seismic shift in the lan
LiberNovo Support Week Goes Live: Up to 44% Off on Maxis, Omni SE and Omni Pro Ergonomic Chair Series25.8.2026 09:00:00 CEST | Press release
HONG KONG, HK / ACCESS Newswire / August 25, 2026 / LiberNovo Support Week is now open across the European Union and the United Kingdom. Through September 8, the Maxis Series, Omni SE, and Omni Pro are up to 44% off in the EU and up to 39% off in the UK, with three gift tiers and triple points for members. The name works two ways. Support your body. LiberNovo chairs respond as you lean in, sit upright, and recline, instead of holding you to one fixed posture. Support your journey. Through Create for Creators, LiberNovo backs the developers, designers, streamers, and gamers who do their work seated. Maxis Series: Built for Bigger Builds The event leads with the Maxis Series, sized from the frame up for taller, broader, and heavier users. A 52 cm seat depth supports more of the thigh, the wider cushion leaves room to shift, and the reinforced structure is rated to 181 kg. Five-stage recline control runs from 105° to 160° on progressive springs, so support holds steady at every angle, inc
Bear Robotics and BOWE IQ Partner to Cut Warehouse Robot Integration From Months to Weeks25.8.2026 07:00:00 CEST | Press release
The new partnership synchronizes Carti 100 AMRs with legacy WMS/ERP/MES environments, reducing deployment lead times by up to 40% at existing facilities. LONDON, UK / ACCESS Newswire / August 25, 2026 / Bear Robotics, which has deployed more than 16,000 autonomous robots across 20 countries, and BOWE IQ, a leading UK-based automation integrator, today announced a partnership to simplify and accelerate the integration of robotic automation into warehouse operations across the United Kingdom and Europe. The collaboration addresses a key challenge in warehouse automation: the technical complexity of connecting robotic fleets with existing warehouse and enterprise systems. By integrating BOWE IQ's software with Bear Robotics' Carti 100 AMRs, operators can more easily connect their robotic fleets to existing Warehouse Management Systems (WMS), Enterprise Resource Planning (ERP) systems, and Manufacturing Execution Systems (MES), reducing the need for bespoke integration and lengthy coding c
DocStyle Announces DocStyle AI: Document Productivity Tools, Accessible from the AI Assistants Lawyers Already Use19.8.2026 16:00:00 CEST | Press release
The new solution connects DocStyle's document engine to Claude for Word, Microsoft Copilot, and a dedicated chat pane, available for pre-order today ahead of general availability on October 1st. MIAMI, FL / ACCESS Newswire / August 19, 2026 / DocStyle, a leading provider of legal document repair, structuring, and automation solutions, today announced DocStyle AI. Rather than embedding a general AI chat into its software, DocStyle made its full document productivity engine accessible from the AI assistants legal professionals already use, including Claude for Word and Microsoft Copilot, alongside a dedicated DocStyle AI chat pane inside the DocStyle Ribbon. Built on the Model Context Protocol (MCP), an open standard, DocStyle AI is vendor-independent by design, staying reachable as AI models change and protecting the customer's investment. "We have always known that when making substantive changes to Word documents, you have to be inside Microsoft Word," said Chris Cangero, CEO of DocSt
Europe SPAC Summit 2026 to Convene Leading SPAC Sponsors, Investors, and European Growth Companies in Zurich on December 1019.8.2026 15:00:00 CEST | Press release
One-Day, Invitation-Only Summit Maps the Path from European Innovation to U.S. Capital Markets NEW YORK, NY AND ZURICH, SWITZERLAND / ACCESS Newswire / August 19, 2026 / As a landmark year for European companies in the U.S. public markets continues to build momentum, the Europe SPAC Summit will convene the dealmakers driving the region's de-SPAC renaissance, turning its focus to deal flow, capital formation, and every stage of the path from European innovation to a thriving U.S. listing. The invitation-only Summit takes place on Thursday, December 10, 2026, at The Dolder Grand in Zurich, Switzerland, co-hosted by AUM Advisors and MBP Global. The Summit features a keynote session with Kyivstar, Ukraine's largest mobile operator, whose successful Nasdaq listing through a merger with a SPAC sponsored by Cohen Circle, the investment platform founded by fintech pioneer Betsy Cohen, demonstrates that this approach can create real value for Europe's growth companies. The program also includes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom